切换至 "中华医学电子期刊资源库"

中华眼科医学杂志(电子版) ›› 2025, Vol. 15 ›› Issue (01) : 21 -26. doi: 10.3877/cma.j.issn.2095-2007.2025.01.004

论著

甲状腺相关性眼病所致限制性斜视临床特征和手术治疗效果的临床研究
鲁翼1, 周炼红2, 张灿灿1, 余露润3, 龚奇3, 袁庆4, 段欧文2   
  1. 1. 430061 武汉大学人民医院眼Ⅳ科2022级硕士研究生
    2. 430061 武汉大学人民医院眼Ⅳ科
    3. 430061 武汉大学人民医院眼Ⅳ科2023级硕士研究生
    4. 430061 武汉大学人民医院2024级硕士研究生
  • 收稿日期:2024-11-06 出版日期:2025-02-28
  • 通信作者: 周炼红
  • 基金资助:
    湖北省重点研发计划项目(2022BCA044)

The clinical features and surgical treatment effectiveness of thyroid-associated ophthalmopathy related restrictive strabismus

Yi Lu1, Lianhong Zhou2, Cancan Zhang1, Lurun Yu3, Qi Gong3, Qing Yuan4, Ouwen Duan2   

  1. 1. Master′s degree 2022,IV Department of Ophthalmology,Renming Hospital of Wuhan University,Wuhan 430061,China
    2. IV Department of Ophthalmology,Renmin Hospital of Wuhan University,Wuhan 430061,China
    3. Master′s degree 2023,IV Department of Ophthalmology,Renming Hospital of Wuhan University,Wuhan 430061,China
    4. Master′s degree 2024,IV Department of Ophthalmology,Renming Hospital ofWuhan University,Wuhan 430061,China
  • Received:2024-11-06 Published:2025-02-28
  • Corresponding author: Lianhong Zhou
引用本文:

鲁翼, 周炼红, 张灿灿, 余露润, 龚奇, 袁庆, 段欧文. 甲状腺相关性眼病所致限制性斜视临床特征和手术治疗效果的临床研究[J/OL]. 中华眼科医学杂志(电子版), 2025, 15(01): 21-26.

Yi Lu, Lianhong Zhou, Cancan Zhang, Lurun Yu, Qi Gong, Qing Yuan, Ouwen Duan. The clinical features and surgical treatment effectiveness of thyroid-associated ophthalmopathy related restrictive strabismus[J/OL]. Chinese Journal of Ophthalmologic Medicine(Electronic Edition), 2025, 15(01): 21-26.

目的

探讨甲状腺相关性眼病(TAO)所致限制性斜视的临床特征和手术治疗效果。

方法

选取2019年1月至2023年3月于武汉大学人民医院眼Ⅳ科因TAO所致限制性斜视行手术治疗TAO患者48例(68只眼)的临床资料。其中,男性33例(44只眼),女性15例(24只眼);年龄33~66岁,平均年龄为(51.7±10.3)岁。所有患者根据术前眼球运动、影像学成像及术中牵拉试验确定受累肌肉,并行受累肌肉的减弱术,包括直肌悬吊术、直肌后徙术、直肌断腱术及A型肉毒素注射,必要时联合拮抗肌加强术。术后随访6个月或1年,检查并记录患者手术前与末次随访斜视度、复视情况、眼压、视力及突眼度。年龄、眼球运动受限、斜视度、术眼眼压、视力及突眼度情况等计量资料符合正态分布,采用¯x±s描述,术前术后比较采用配对t检验。病程和甲状腺功能障碍与斜视间隔时间不符合正态分布,采用四分位数描述;计数资料用例数和百分比描述。

结果

48例(68只眼)患者斜视病程为5~108个月,中位病程为12个月,甲状腺功能障碍病程为7~120个月,中位病程为20个月;甲状腺功能障碍与斜视中位间隔时间为0~114个月,中位间隔时间为6个月。全部患者48例(68只眼)中既往诊断为Graves病有45例(64只眼),甲状腺乳头状癌有2例(3只眼),桥本甲状腺炎有1例(1只眼),分别占94.12%、4.41%及1.47%。所有患者眼眶影像学成像均提示存在眼外肌受累。斜视与甲状腺功能异常同时出现者9例(12只眼),斜视后出现甲状腺功能异常者39例(56只眼),分别占18.75%和81.25%。所有患者术前甲状腺功能均无甲状腺功能亢进症表现。垂直斜视合并内斜视者32例(44只眼),垂直斜视合并外斜视者2例(4只眼),垂直斜视者8例(10只眼),内斜视者6例(10只眼),分别占66.67%、4.17%、16.67%及12.50%。眼眶影像学成像显示48例(68只眼)患者均存在不同程度眼外肌受累。其中,存在下直肌受累、上直肌受累、内直肌受累及外直肌受累者分别为40例(61只眼)、31例(46只眼)、26例(45只眼)及8例(10只眼),分别占83.33%、64.58%、54.17%及16.67%。累计共162条眼外肌增粗,存在2条以上眼外肌受累者36例(56只眼),仅为1条眼外肌受累者12例(12只眼),分别占75%和25%。45例(68只眼)中有81条眼外肌行手术治疗,均为直肌。78条直肌行减弱手术,单条肌肉减弱术者28例(28只眼),两条肌肉减弱术者14例(28只眼),两条以上肌肉减弱术者6例(12只眼),分别占58.33%、29.17%及12.5%。45例(64只眼)术眼术前眼压平均值为(24.19±9.26)mmHg(1 mmHg=0.133 kPa),术后眼压平均值为(19.99±7.00)mmHg,术后眼压较术前降低,比较的差异有统计学意义(t=5.695,P<0.05);术前平均视力为(4.82±0.50)最小分辨角的对数(logMAR),术后平均视力为(4.86±0.45)logMAR,术后视力有明显提升,比较的差异有统计学意义(t=1.995,P<0.05);术眼术前突眼度平均值为(19.80±2.22)mm,术后突眼度平均值为(17.60±2.14)mm,术后突眼度较术前回退,比较的差异有统计学意义(t=14.408,P<0.05)。

结论

TAO所致限制性斜视患者主要表现为多条眼外肌受累的斜视,下直肌和内直肌常受累,受限肌肉的减弱术有效,必要时可联合拮抗肌加强术。

Objective

The aim of this study is to analyze the clinical characteristics and surgical outcomes of restrictive strabismus caused by thyroid-associated ophthalmopathy(TAO).

Methods

A total of 48 TAO patients(68 eyes)who underwent surgical intervention for restrictive strabismus at the Department of Ophthalmology,Renmin Hospital of Wuhan University,between January 2019 and March 2023 were retrospectively collected.The final participants included 33 males(44 eyes)and 15 females(24 eyes)with amean age of(51.7±10.3)years(ranging from 33 to 66).Affected extraocularmuscles were identified preoperatively via ocularmotility assessments,imaging,and intraoperative forced pull tests.Surgical strategies included extraocularmuscle tenotomy,suspension surgery,retraction surgery,or type A botulinum toxin injection,with additional strengthening surgery for residual deviation.Patientswere followed up for 6 months or 1 year after surgery and analyzed for differences of in ocular deviation,diplopia,intraocular pressure,visual acuity,and proptosis between the preoperative period and the last follow-up.Measurements of age,limitation degree of ocularmotility,strabismus deviation,intraocular pressure,visual acuity,and proptosiswere described as¯x±s when they conformed to normal distribution,and compared by t tests;paired t tests were used for preoperative and postoperative comparisons.Disease duration and the interval between thyroid dysfunction and strabismus were described by quartiles due to they did not conform to normal distribution;count data were described by number of cases and percentage.

Results

The duration of strabismus ranged from 5 to 108 months,with amedian duration of12 months,and the duration of thyroid dysfunction ranged from 7 to 120 months,with amedian duration of20months;themedian interval between thyroid dysfunction and strabismus ranged from 0 to 114 months,with a median interval of 6 months.45 patients(64 eyes)had a previous diagnosis of TAO,2 cases(3 eyes)with papillary thyroid carcinoma,and 1 case(1 eye)with Hashimoto′s thyroiditis,accounting for 94.12%,4.41% and 1.47%,respectively.All patients had orbital imaging suggestive of extraocularmuscle involvement.Strabismus and thyroid function abnormality appeared simultaneously in 9 cases(12 eyes),accounting for 18.75%;39 cases(56 eyes)with strabismus after thyroid function abnormality,accounting for 81.25%.None of the patients showed hyperthyroidism in their preoperative thyroid function.Strabismus patterns included vertical deviation with esotropia(32 cases,44 eyes,accounting for 66.67%),vertical deviation with exotropia(2 cases,4 eyes,accounting for 4.17%),isolated vertical deviation(8 cases,10 eyes,16.67%),and isolated esotropia(6 cases,10 eyes,accounting for 12.50%).Orbital imaging demonstrated extraocular muscle thickening in 162 muscles across 48 patients(68 eyes).Specifically,involvement of the inferior rectus(40 cases,61 eyes,accounting for 83.33%),superior rectus(31 cases,46 eyes,accounting for 64.58%),medial rectus(26 cases,45 eyes,accounting for 54.17%),and lateral rectus(8 cases,10 eyes,accounting for 16.67%)was observed.Multimuscular involvement(≥2 muscles)occurred in 36 cases(56 eyes,accounting for 75%),while 12 cases(12 eyes,accounting for 25%)exhibited singlemuscle involvement.Surgical intervention targeted 81 rectus muscles(78 weakened,3 strengthened).Weakening procedures included single-muscle recession(28 cases,28 eyes,accounting for58.33%),twomuscle recession(14 cases,28 eyes,accounting for 29.17%),and multimuscular recession(6 cases,12 eyes,accounting for 12.5%).The average preoperative intraocular pressure of 45 cases(64 eyes)was(24.19±9.26)mmHg(1 mmHg=0.133 kPa),and the average postoperative intraocular pressure was(19.99±7.00)mmHg.The postoperative intraocular pressure decreased compared to preoperative levels,and the differencewas statistically significant(t=5.695,P<0.05).The preoperative average visual acuity was(4.82±0.50)logarithm of theminimum angle of resolution(logMAR),and the postoperative average visual acuity was(4.86±0.45)logMAR.There was a significant improvement in postoperative visual acuity,and the difference was statistically significant(t=1.995,P<0.05).The average preoperative protrusion degree was(19.80±2.22)mm,and the average postoperative protrusion degree was(17.60±2.14)mm.The postoperative protrusion degree decreased compared to preoperative,and the difference was statistically significant(t=14.408,P<0.05).

Conclusions

TAO-induced restrictive strabismus predominantly involvesmultiple extraocularmuscles,particularly the inferior and medial rectus.Weakening procedures for restricted muscles,with adjunctive antagonist muscle strengthening when necessary,effectively restore ocular alignment and improve functional outcomes.

图1 甲状腺相关性眼病所致限制性斜视患者的电子计算机断层扫描成像 患者男性,36岁,因“视物重影半年”于1年前就诊,诊断为甲状腺功能亢进症,术前三棱镜交替遮盖检查结果显示33 cm处-5Δ R/L 50Δ;6 m处R/L 50Δ。图A示术前横轴位成像,见左眼下直肌梭性增粗;图B示术前左眼矢状位成像,见左眼下直肌梭形增粗,左眼下斜视;图C示术前冠状位成像,见左眼下直肌增粗
表1 甲状腺相关性眼病患者手术前后术眼眼球运动受限、斜视度及术眼眼压、视力及突眼度情况的比较(¯x±s
[1]
Taylor PN,Zhang L,Lee RWJ,et al.New insights into the pathogenesis and nonsurgical management of Graves orbitopathy[J].Nat Rev Endocrinol,2020,16(2):104-116.
[2]
Liu Z,Ke SR,Shi ZX,et al.Dynamic transition of Tregs to cytotoxic phenotype amid systemic inflammation in Graves’ophthalmopathy[J].JCI Insight,2024,9(22):e181488.
[3]
Buonfiglio F,Ponto KA,Pfeiffer N,et al.Redoxmechanisms in autoimmune thyroid eye disease[J].Autoimmun Rev,2024,23(5):103534.
[4]
Ma Q,Hai Y,Duan Y,etal.Inflammatory profiling and immune cell infiltration in dysthyroid optic neuropathy:insights from bulk RNA sequencing[J].Front Immunol,2025,16:185.
[5]
Fernando R,Atkins S,RaychaudhuriN,etal.Human fibrocytes coexpress thyroglobulin and thyrotropin receptor[J].Proc Natl Acad Sci,2012,109(19):7427-7432.
[6]
Kim JY,Park S,Lee HJ,et al.Functionally enhanced placentaderived mesenchymal stem cells inhibit adipogenesis in orbital fibroblasts with Graves’ophthalmopathy[J].Stem Cell Res Ther,2020,11(1):726.
[7]
Li Z,Wang M,Tan J,etal.Single-cell RNA sequencing depicts the local cell landscape in thyroid-associated ophthalmopathy[J].Cell Rep Med,2022,3(8):100699.
[8]
Bahn RS.Graves′Ophthalmopathy[J].N Engl JMed,2010,362(8):726-738.
[9]
Lanzolla G,Marinò M,Menconi F.Graves disease:latest understanding of pathogenesis and treatment options[J].Nat Rev Endocrinol,2024,20(11):647-660.
[10]
Shu X,Shao Y,Chen Y,et al.Immune checkpoints:new insights into the pathogenesis of thyroid eye disease[J].Front Immunol,2024,PMID:38817600.
[11]
Bartalena L,Tanda ML.Current concepts regarding Graves′orbitopathy[J].J Intern Med,2022,292(5):692-716.
[12]
Al-BadriWKW,Jellema HM,Potvin ARGG,etal.Psychological aspects of Graves′ophthalmopathy[J].Endocr Connect,2024,13(9):e240259.
[13]
Chen YY,Wei YH,Liao SL.Postoperative residual vertical deviation affects quality of life in Asian patients with thyroidassociated ophthalmopathy(Graves ophthalmopathy)[J].Jpn J Ophthalmol,2023,67(3):326-334.
[14]
Chen M,Tang S,Yan J.Assessment of surgical strategies for management of complicated strabismus reoperation in Graves’ophthalmopathy[J].Int Ophthalmol,2024,44(1):19.
[15]
Eckstein A,Schittkowski M,Esser J.Surgical treatment of Graves′ophthalmopathy[J].Best Pract Res Clin Endocrinol Metab,2012,26(3):339-358.
[16]
Suo NC,Lei CL,Zhang YC,et al.Effects of latanoprost on the expression of TGF-β1 and Wnt/β-catenin signaling pathway in the choroid of form-deprivation myopia rats[J].Cell Mol Biol,2020,66(6):71-75.
[17]
Boulakh L,Nygaard B,Bek T,et al.Nationwide incidence of thyroid eye disease and cumulative incidence of strabismus and surgical interventions in Denmark[J].JAMA Ophthalmol,2022,140(7):667.
[18]
Marino M,Rotondo DG,Menconi F,et al.Role of genetics and epigenetics in Graves′orbitopathy[J].Eur Thyroid J,2024,13(6):e240179.
[19]
Wang Y,Gao S,Cao F,et al.Ocular immune-related diseases:molecular mechanisms and therapy[J].Med Comm,2024,5(12):207.
[20]
Kim DW,Kim S,Han J,et al.Transcriptomic profiling of thyroid eye disease orbital fat demonstrates differences in adipogenicity and IGF-1R pathway[J].JCI Insight,2024,PMID:39704170.
[21]
Chang HH,Wu SB,Tsai CC.A review of pathophysiology and therapeutic strategies targeting TGF-βin Graves′ophthalmopathy[J].Cells,2024,13(17):1493.
[22]
Akbari MR,Ameri A,Keshtkar Jaafari AR,et al.Botulinum toxin injection for restrictive myopathy of thyroid-associated orbitopathy:success rate and predictive factors[J].J AAPOS,2016,20(2):126-130.
[23]
崔好好,邵庆.A型肉毒素在甲状腺相关眼病治疗中的应用[J].国际眼科杂志,2023,23(7):1120-1125.
[24]
AkbariMR,Mirmohammadsadeghi A,Mahmoudzadeh R,et al.Management of thyroid eye disease-related strabismus[J].JCurr Ophthalmol,2020,32(1):1-13.
[25]
Wei L,Huang Q,Tu Y,et al.Plasma exosomes from patients with active thyroid-associated orbitopathy induce inflammation and fibrosis in orbital fibroblasts[J].J Transl Med,2024,22(1):994.
[26]
吴元.甲状腺相关斜视的治疗策略[J].中国斜视与小儿眼科杂志,2021,29(1):42-45.
[27]
许丽敏,荣军博,郎丽娟,等.甲状腺相关眼病所致限制性斜视的手术效果[J].中华眼外伤职业病杂志,2021,43(5):328-333.
[28]
Lu TJ,Amarikwa L,Sears CM,et al.Advances in the treatment of thyroid eye disease associated extraocularmusclemyopathy and optic neuropathy[J].Curr Neurol Neurosci Rep,2022,22(6):313-325.
[29]
Dal-Canto AJ,Crowe S,Perry JD,et al.Intraoperative relaxed muscle positioning technique for strabismus repair in thyroid eye disease[J].Ophthalmology,2006,113(12):2324-2330.
[30]
Nguyen VT,Park DJJ,Levin L,et al.Correction of restricted extraocularmuscle motility in surgical management of strabismus in Graves′ophthalmopathy[J].Ophthalmology,2002,109(2):384-388.
[31]
Liao SL,Wei YH,Chuang AC.The role of rectus muscle myectomy in themanagementof large-angle strabismus for Graves′ophthalmopathy[J].Eye(Lond),2017,31(7):1027-1033.
[32]
马惠芝,李宁冬,赵堪兴,等.直肌悬吊术在治疗甲状腺相关性眼病手术中的应用[J].中国实用眼科杂志,2007,25(7):796-798.
[33]
郑磊,阙传红.甲状腺相关性眼病所致限制性斜视手术效果观察[J].中华眼外伤职业病杂志,2015,37(6):447-449.
[34]
Tian H,Wang Y,Li J,et al.Prognostic value of extraocular muscles for intraocular pressure in thyroid-associated ophthalmopathy patients[J].Quant Imaging Med Surg,2023,13(9):5727-5736.
[35]
Li X,Bai X,Liu Z,et al.The effect of inferior rectusmuscle thickening on intraocular pressure in thyroid-associated ophthalmopathy[J].JOphthalmol,2021,PMID:33564471.
[1] 陈向军, 于丽, 王星, 梁俊青, 吴迪, 李志军. 采用不同方法联合放射治疗修复薄型瘢痕疙瘩的临床疗效分析[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(03): 215-222.
[2] 陈浩, 王萌. 胃印戒细胞癌的临床病理特征及治疗选择的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 108-111.
[3] 刘连新, 孟凡征. 不断提高腹腔镜解剖性肝切除的规范化[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(04): 355-358.
[4] 中华医学会外科学分会疝与腹壁外科学组, 中国医师协会外科医师分会疝和腹壁外科专家工作组. 腹股沟疝诊疗指南(2024 版)[J/OL]. 中华疝和腹壁外科杂志(电子版), 2025, 19(01): 1-8.
[5] 中华医学会外科学分会疝与腹壁外科学组, 中国医师协会外科医师分会疝和腹壁外科专家工作组. 腹壁切口疝诊疗指南(2024 版)[J/OL]. 中华疝和腹壁外科杂志(电子版), 2025, 19(01): 9-17.
[6] 蒋凤茹, 朱熠林. 双腔造瘘口旁疝诊疗经验[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(05): 534-537.
[7] 仝聪, 周哲琦, 阎立昆. 食管裂孔疝合并胃食管反流病治疗现状及与胃食管结合部肿瘤的关系[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(05): 491-493.
[8] 翁桂湖, 刘悦泽, 张太平. 胰腺神经内分泌肿瘤治疗进展与争议[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 602-606.
[9] 邱小原, 刘雨馨, 李珂璇, 林国乐, 邱辉忠, 安燚. 直肠肿瘤术后直肠阴道瘘的外科治疗[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(05): 423-430.
[10] 曲洋, 蒋浩然, 邢博涵, 张蒙, 张培训. 肩袖损伤的治疗进展[J/OL]. 中华肩肘外科电子杂志, 2024, 12(04): 289-291.
[11] 赵晞淯, 李俊红, 王晓刚. 斜视患者眼外肌术后视网膜与脉络膜变化的研究进展[J/OL]. 中华眼科医学杂志(电子版), 2024, 14(04): 227-232.
[12] 曹文钰, 郭鹏, 李锦平. 微创手术及非手术方式治疗慢性硬膜下血肿的研究进展[J/OL]. 中华神经创伤外科电子杂志, 2024, 10(05): 304-309.
[13] 李晓东, 李昂, 马龙, 刘亮, 魏云, 王汉宇. 基底动脉顶端动脉瘤显微手术治疗[J/OL]. 中华神经创伤外科电子杂志, 2024, 10(04): 254-256.
[14] 景方坤, 周建波, 王全才, 黄海韬, 李岩峰, 徐杨熙. 神经导航引导下治疗基底节高血压脑出血的短期疗效预测[J/OL]. 中华脑科疾病与康复杂志(电子版), 2024, 14(03): 154-159.
[15] 刘虎, 任振, 韦笑韩, 潘晨, 吴立胜. 胃食管反流伴食管运动障碍的诊疗进展[J/OL]. 中华胃食管反流病电子杂志, 2024, 11(03): 153-158.
阅读次数
全文
0
HTML PDF
最新录用 在线预览 正式出版 最新录用 在线预览 正式出版
0 0 0 0 0 0


摘要
10
最新录用 在线预览 正式出版
0 0 10
  来源 本网站 其他网站
  次数 1 9
  比例 10% 90%